Entera Bio Ltd. 8-K/A Report: Key Financial Insights & Stock Details

Based on the provided XML section of the financial report, here are the key insights and information extracted:

1. Entity Information:

• Company Name: Entera Bio Ltd.
• CIK (Central Index Key): 0001638097
• SEC Filing Type: 8-K/A (Amendment to a current report)

2. Reporting Date:

• Period End Date: July 31, 2024

3. Stock Information:

• Ordinary Shares:
• • Par Value: NIS 0.0000769 (New Israeli Shekel)
• Warrants:
• • Description: Each warrant is exercisable for half of an ordinary share.
  • Exercise Price: $5.85 per ordinary share.

4. Contact Information:

• Address: L3 001-38556 Kiryat Hadassah, Minrav Building, Fifth Floor, Jerusalem, IL 9112002
• Phone Number: 972-2-532-7151

5. Stock Exchange:

• The company is listed on NASDAQ under the ticker symbol ENTX.

Summary:

Entera Bio Ltd. has reported an updated financial filing as of July 31, 2024, detailing its ordinary shares and associated warrants. The ordinary shares have a nominal value in NIS, while the warrants can be converted into shares at a defined exercise price of $5.85. The information is crucial for investors monitoring Entera Bio Ltd.'s capital structure and potential dilution from warrant exercises.